A global pharmaceutical giant was facing limitations in data management due to a traditional on-premises analytical pipeline. The current system was slow and did not offer flexibility and scalability to accommodate their growing data needs. Moreover, multiple siloed data sets, and lack of provision for using AI, analytics was depriving the teams of key opportunities to make data-backed decision-making.

The client was looking for an expert partner to migrate their analytical pipeline to AWS and utilize its advanced security features such as security groups and network access control lists, to enable inbound and outbound filtering.

Our AWS experts at i2e understood the client’s requirements and developed a scalable and serverless data pipeline using AWS services. The team integrated data from multiple sources, they then cleaned, de-duplicated and transformed the data to AWS Redshift for use of data analysts and scientists in S3 buckets.

The team used AWS Glue for preparing and loading the data for downstream analytics. The client had an existing Tableau license, so we integrated the pipeline with Tableau for data visualization and reporting.

This serverless approach gave the client not only the cost advantage, but also solved data siloes, flexibility and scalability issues. The entire infrastructure was built within an Amazon Virtual Private Cloud (VPC) setup which is easy-to-use, customizable and provides advanced security features.